GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novomics Co Ltd (XKRX:283100) » Definitions » Float Percentage Of Total Shares Outstanding

Novomics Co (XKRX:283100) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 25, 2025)


View and export this data going back to 2023. Start your Free Trial

What is Novomics Co Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Novomics Co's float shares is 0.00 Mil. Novomics Co's total shares outstanding is 7.70 Mil. Novomics Co's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Novomics Co's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Novomics Co's Institutional Ownership is 0.00%.


Novomics Co Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Novomics Co's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/7.70
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novomics Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novomics Co Ltd (XKRX:283100) » Definitions » Float Percentage Of Total Shares Outstanding
Traded in Other Exchanges
N/A
Address
171 Dangsan-ro, 304, 305, 306, 306-1, Yeongdeungpo-gu, Seoul, KOR
Novomics Co Ltd is a developer of a molecular diagnosis system for cancer treatment.

Novomics Co Headlines

No Headlines